Amgen (AMGN) Share-based Compensation (2009 - 2026)

Amgen (AMGN) has reported Share-based Compensation for 14 consecutive years, with $75.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation fell 11.76% year-over-year to $75.0 million; the TTM figure through Mar 2026 stood at $484.0 million (down 5.47% YoY), while the FY2025 annual figure was $494.0 million, down 6.79% from the prior year.
• Share-based Compensation came in at $75.0 million for Q1 2026 at Amgen, down from $125.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $161.0 million in Q4 2023, with the low at $47.0 million in Q1 2023.
• Average Share-based Compensation over 4 years is $117.7 million, with a median of $125.0 million recorded in 2025.
• Across the five-year window, Share-based Compensation soared 119.15% in 2024 and declined 17.48% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $161.0 million in 2023, then fell by 16.77% to $134.0 million in 2024, then dropped by 6.72% to $125.0 million in 2025, then tumbled by 40.0% to $75.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $75.0 million, $125.0 million, and $127.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.